Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 891
Filtrar
Más filtros

Intervalo de año de publicación
1.
BMC Med Res Methodol ; 24(1): 204, 2024 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-39271998

RESUMEN

BACKGROUND: The aim of this study is to analyze the trend of acute onset of chronic cor pulmonale at Chenggong Hospital of Kunming Yan'an Hospital between January 2018 and December 2022.Additionally, the study will compare the application of the ARIMA model and Holt-Winters model in predicting the number of chronic cor pulmonale cases. METHODS: The data on chronic cor pulmonale cases from 2018 to 2022 were collected from the electronic medical records system of Chenggong Hospital of Kunming Yan'an Hospital. The ARIMA and Holt-Winters models were constructed using monthly case numbers from January 2018 to December 2022 as training data. The performance of the model was tested using the monthly number of cases from January 2023 to December 2023 as the test set. RESULTS: The number of acute onset of chronic cor pulmonale in Chenggong Hospital of Kunming Yan'an Hospital exhibited a downward trend overall from 2018 to 2022. There were more cases in winter and spring, with peaks observed in November to December and January of the following year. The optimal ARIMA model was determined to be ARIMA (0,1,1) (0,1,1)12, while for the Holt-Winters model, the optimal choice was the Holt-Winters multiplicative model. It was found that the Holt-Winters multiplicative model yielded the lowest error. CONCLUSION: The Holt-Winters multiplicative model predicts better accuracy. The diagnosis of acute onset of chronic cor pulmonale is related to many risk factors, therefore, when using temporal models to fit and predict the data, we must consider such factors' influence and try to incorporate them into the models.


Asunto(s)
Modelos Estadísticos , Enfermedad Cardiopulmonar , Humanos , Enfermedad Cardiopulmonar/epidemiología , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Crónica , Estaciones del Año , China/epidemiología , Masculino , Femenino , Enfermedad Aguda , Registros Electrónicos de Salud/estadística & datos numéricos , Predicción/métodos , Persona de Mediana Edad
2.
J Assoc Physicians India ; 70(5): 11-12, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35598131

RESUMEN

AIMS AND OBJECTIVES: Patients with pulmonary thromboembolism (PTE) are commonly admitted to hospital and generally have a prolonged hospital stay in this part of the world. We aimed to determine different clinical and laboratory parameters that are associated with prolonged hospital stay in our set-up and to analyse effectiveness of Pulmonary Embolism Severity Index (PESI) score as a predictor of prolonged hospital stay in patients with PTE. MATERIALS AND METHODS: It was a hospital based observational prospective study. Confirmed cases of PTE defined as patients with evidence of thrombus on CT pulmonary angiogram (CTPA) were included in this study. Depending on the length of hospital stay, patients were divided into two cohorts: Shorter Hospital stay (less than mean i.e., < 10 Days) and Prolonged Hospital stay (longer than mean i.e., ≥ 10 Days). Logistic regression analysis was done to identify predictors of prolonged hospital stay. RESULTS: 150 patients were included in the study with 67 patients (44.67%) having shorter hospital stay (<10 days) and 83 patients (55.33%) having prolonged hospital stay (≥10 days). On multivariate regression analysis, parameters that were found to be statistically significant were hypotension at presentation, decreased level of consciousness, pco2 < 30 mmHg, presence of S1Q3T3 pattern on electrocardiogram (ECG) and high risk PESI (class III-V). CONCLUSION: PESI class can be effectively used to predict prolonged hospital stay in patients with pulmonary embolism. Patients with hypotension at presentation, decreased level of consciousness, pco2 less than 30 mmHg, and S1Q3T3 on ECG are more likely to have prolonged hospital stay in our healthcare setup.


Asunto(s)
Tiempo de Internación , Embolia Pulmonar , Enfermedad Aguda , Dióxido de Carbono/sangre , Angiografía por Tomografía Computarizada , Trastornos de la Conciencia/etiología , Electrocardiografía , Humanos , Hipotensión/etiología , Estudios Prospectivos , Embolia Pulmonar/sangre , Embolia Pulmonar/complicaciones , Embolia Pulmonar/diagnóstico por imagen , Embolia Pulmonar/terapia , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/etiología , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad
3.
Am J Emerg Med ; 48: 376.e1-376.e2, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-33958247

RESUMEN

The pediatric population accounts for a small portion of those with severe disease related to COVID-19. There are few published reports of hypercoagulable states in children with COVID-19. We describe an 11-year-old male with nephrotic syndrome who required inpatient treatment for COVID-19 pneumonia eight weeks prior. He returned to the emergency department with vomiting, tachypnea and was found to have a pulmonary embolism. In this case report, we discuss the risk factors for, presentation and evaluation of hypercoagulable state and its relation to COVID-19 in a pediatric patient.


Asunto(s)
COVID-19/sangre , Síndrome Nefrótico/complicaciones , Embolia Pulmonar/diagnóstico , Enfermedad Cardiopulmonar/diagnóstico , Trombofilia/sangre , COVID-19/complicaciones , Niño , Angiografía por Tomografía Computarizada , Electrocardiografía , Fibrinolíticos/uso terapéutico , Heparina/uso terapéutico , Hospitalización , Humanos , Unidades de Cuidado Intensivo Pediátrico , Masculino , Readmisión del Paciente , Obesidad Infantil/complicaciones , Embolia Pulmonar/sangre , Embolia Pulmonar/complicaciones , Embolia Pulmonar/tratamiento farmacológico , Enfermedad Cardiopulmonar/tratamiento farmacológico , Enfermedad Cardiopulmonar/etiología , SARS-CoV-2 , Taquipnea , Trombofilia/complicaciones , Trombofilia/tratamiento farmacológico , Activador de Tejido Plasminógeno/uso terapéutico , Vómitos
4.
Eur Respir J ; 49(6)2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28619955

RESUMEN

A pulmonary artery to aorta ratio (PA:A) >1 is a proxy of pulmonary hypertension. It is not known whether this measure carries prognostic information in the general population and in individuals with chronic obstructive pulmonary disease (COPD).Between 2003 and 2006, 2197 participants from the population-based Rotterdam Study (mean±sd age 69.7±6.7 years; 51.3% female), underwent cardiac computed tomography (CT) scanning with PA:A quantification, defined as the ratio between the diameters of the pulmonary artery and the aorta. COPD was diagnosed based on spirometry or clinical presentation and obstructive lung function measured by a treating physician. Cox regression was used to investigate the risk of mortality.We observed no association between 1-sd increase of PA:A and mortality in the general population. Larger PA:A was associated with an increased risk of mortality in individuals with COPD, particularly in moderate-to-severe COPD (hazard ratio 1.36, 95% CI 1.03-1.79). We demonstrated that the risk of mortality in COPD was driven by severe COPD, and that this risk increased with decreasing diffusing capacity.Larger PA:A is not associated with mortality in an older general population, but is an independent determinant of mortality in moderate-to-severe COPD. Measuring PA:A in CT scans obtained for other indications may yield important prognostic information in individuals with COPD.


Asunto(s)
Aorta , Hipertensión Pulmonar , Arteria Pulmonar , Capacidad de Difusión Pulmonar , Enfermedad Pulmonar Obstructiva Crónica , Enfermedad Cardiopulmonar , Anciano , Aorta/diagnóstico por imagen , Aorta/fisiopatología , Estudios de Cohortes , Femenino , Humanos , Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/fisiopatología , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Pronóstico , Arteria Pulmonar/diagnóstico por imagen , Arteria Pulmonar/fisiopatología , Capacidad de Difusión Pulmonar/métodos , Capacidad de Difusión Pulmonar/fisiología , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/mortalidad , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/etiología , Enfermedad Cardiopulmonar/fisiopatología , Medición de Riesgo , Factores de Riesgo , Índice de Severidad de la Enfermedad , Espirometría/métodos , Tomografía Computarizada por Rayos X/métodos
5.
Am J Hematol ; 92(2): 125-130, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27806442

RESUMEN

Cardiopulmonary disease is the leading cause of mortality in adults with sickle cell disease (SCD). Elevated tricuspid regurgitant jet velocity (TRJV) and reduced forced expiratory volume in 1 second (FEV1 ) %predicted are associated with early mortality in SCD; however their relationship and combined effect on survival is unknown. We investigated the relationship between TRJV and FEV1 %predicted, and their combined effect on mortality, in a retrospective cohort of 189 adults with SCD who underwent both pulmonary function testing and echocardiography. Nineteen (9.9%) of 189 patients died over a median follow-up of 1.4 years; cardiopulmonary disease was the major cause of death in 52.6%. FEV1 %predicted was negatively associated with TRJV (Spearman rho, -0.34, P < 0.001). Individuals with FEV1 %predicted ≤70% were more likely to have an elevated TRJV ≥2.5 m/second, compared to those with FEV1 %predicted >70% [45.8% versus 17.1%; odds ratio (OR) 4.1 (95% Confidence interval ([CI] 2.1-8.0); P = 0.001]. In a multivariable cox regression model, the combination of TRJV ≥2.5 m/second and FEV1 %predicted ≤70% predicted earlier mortality [hazard ratio (HR) 4.97 (95% CI 1.30-18.91; P = 0.019)] after adjusting for age, sex, and nephropathy. Both FEV1 %predicted ≤70% and TRJV ≥2.5 m/second were independently associated with nephropathy [OR 4.48 (95% CI 1.51-13.31); P = 0.004] and [OR 3.27 (95% CI 1.19-9.00); P = 0.017], respectively. In conclusion, pulmonary and cardiac impairment are associated with, and contribute to mortality in SCD. Therapies aimed at improving reduced FEV1 %predicted and elevated TRJV could improve survival in patients with SCD. Am. J. Hematol. 92:125-130, 2017. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Anemia de Células Falciformes/complicaciones , Volumen Espiratorio Forzado , Insuficiencia de la Válvula Tricúspide/mortalidad , Adulto , Anciano , Anemia de Células Falciformes/mortalidad , Estudios de Cohortes , Ecocardiografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/mortalidad , Pruebas de Función Respiratoria , Estudios Retrospectivos , Tasa de Supervivencia
7.
Blood Cells Mol Dis ; 57: 1-7, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26852648

RESUMEN

BACKGROUND: Cardiovascular involvement represents a leading cause of mortality and morbidity in sickle cell disease (SCD). Apelin is a peptide involved in the regulation of cardiovascular function. AIM: To determine serum apelin among 40 children and adolescents with SCD compared with 40 healthy controls and assess its relation to markers of hemolysis, iron overload as well as cardiopulmonary complications. METHODS: SCD patients, in steady state and asymptomatic for heart disease, were studied stressing on hydroxyurea/chelation therapy, hematological profile, serum ferritin and apelin levels. Full echocardiographic study including assessment of biventricular systolic function and pulmonary artery pressure was done. RESULTS: Apelin levels were significantly lower in SCD patients compared with controls (P<0.001). Cardiopulmonary complications were encountered in 30% of patients. Apelin was significantly decreased among patients with cardiopulmonary disease (P=0.006) whether those at risk of pulmonary hypertension (P=0.018) or patients with heart disease (P=0.043). Hydroxyurea-treated patients had higher apelin levels than untreated ones (P=0.001). Apelin was negatively correlated to lactate dehydrogenase, indirect bilirubin, serum ferritin, end systolic diameter, tricuspid regurgitant jet velocity, right ventricle systolic pressure, pulmonary vascular resistance and tissue Doppler imaging S wave. Apelin cutoff value of 1650ng/L could significantly detect the presence of cardiopulmonary complications in SCD with 90.9% sensitivity and 72.4% specificity. CONCLUSION: Apelin is a promising marker for screening of SCD patients at risk of cardiopulmonary disease because it is altered during the early subclinical stage of cardiac affection. A combination of apelin and echocardiography provides a reliable method to assess cardiopulmonary affection in young SCD patients.


Asunto(s)
Anemia de Células Falciformes/sangre , Hipertensión Pulmonar/sangre , Sobrecarga de Hierro/sangre , Enfermedad Cardiopulmonar/sangre , Insuficiencia de la Válvula Tricúspide/sangre , Adolescente , Anemia de Células Falciformes/complicaciones , Anemia de Células Falciformes/diagnóstico , Anemia de Células Falciformes/diagnóstico por imagen , Antidrepanocíticos/uso terapéutico , Apelina , Presión Arterial/efectos de los fármacos , Bilirrubina/sangre , Biomarcadores/sangre , Presión Sanguínea/efectos de los fármacos , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Ferritinas/sangre , Hemólisis , Humanos , Hidroxiurea/uso terapéutico , Hipertensión Pulmonar/complicaciones , Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/diagnóstico por imagen , Péptidos y Proteínas de Señalización Intercelular/sangre , Quelantes del Hierro/uso terapéutico , Sobrecarga de Hierro/complicaciones , Sobrecarga de Hierro/diagnóstico , Sobrecarga de Hierro/diagnóstico por imagen , L-Lactato Deshidrogenasa/sangre , Masculino , Enfermedad Cardiopulmonar/complicaciones , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/diagnóstico por imagen , Sensibilidad y Especificidad , Insuficiencia de la Válvula Tricúspide/complicaciones , Insuficiencia de la Válvula Tricúspide/diagnóstico , Insuficiencia de la Válvula Tricúspide/diagnóstico por imagen , Ultrasonografía , Resistencia Vascular/efectos de los fármacos
8.
J Integr Neurosci ; 15(1): 19-35, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26916209

RESUMEN

The proposed method of quantitative estimation of regulatory and adaptive status (RAS) of human organism is based on complex responses of two major vegetative functions - breath and heart rates under organism exposure to a number of factors and diseases. It has been evidenced that during the follicular menstruation stage and during optimum readiness of female organism for childbirth RAS increases, however, stress impact can also cause RAS set off to decrease. Likewise, the possibility of quantitative organism stress resistance estimation is also presented. Under some pathological conditions (myocardial infarction, hypo-and hyperthyroidism, diabetes type 2), RAS goes down, and the degree of its restoration depends on the attained therapy effect. It is shown that RAS dynamics provides an innovative methodological approach to medication efficiency estimation based on its influence not only on the body organ or target function, but also on adaptive abilities of the organism.


Asunto(s)
Adaptación Fisiológica/fisiología , Frecuencia Cardíaca/fisiología , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/fisiopatología , Respiración , Adolescente , Adulto , Factores de Edad , Femenino , Humanos , Adulto Joven
10.
Crit Care ; 19: 174, 2015 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-25887151

RESUMEN

INTRODUCTION: Acute cor pulmonale (ACP) and patent foramen ovale (PFO) remain common in patients under protective ventilation for acute respiratory distress syndrome (ARDS). We sought to describe the hemodynamic profile associated with either ACP or PFO, or both, during the early course of moderate-to-severe ARDS using echocardiography. METHODS: In this 32-month prospective multicenter study, 195 patients with moderate-to-severe ARDS were assessed using echocardiography during the first 48 h of admission (age: 56 (SD: 15) years; Simplified Acute Physiology Score: 46 (17); PaO2/FiO2: 115 (39); VT: 6.5 (1.7) mL/kg; PEEP: 11 (3) cmH2O; driving pressure: 15 (5) cmH2O). ACP was defined by the association of right ventricular (RV) dilatation and systolic paradoxical ventricular septal motion. PFO was detected during a contrast study using agitated saline in the transesophageal bicaval view. RESULTS: ACP was present in 36 patients, PFO in 21 patients, both PFO and ACP in 8 patients and the 130 remaining patients had neither PFO nor ACP. Patients with ACP exhibited a restricted left ventricle (LV) secondary to RV dilatation and had concomitant RV dysfunction, irrespective of associated PFO, but preserved LV systolic function. Despite elevated systolic pulmonary artery pressure (sPAP), patients with isolated PFO had a normal RV systolic function. sPAP and PaCO2 levels were significantly correlated. CONCLUSIONS: In patients under protective mechanical ventilation with moderate-to-severe ARDS, ACP was associated with LV restriction and RV failure, whether PFO was present or not. Despite elevated sPAP, PFO shunting was associated with preserved RV systolic function.


Asunto(s)
Foramen Oval Permeable/etiología , Hemodinámica , Enfermedad Cardiopulmonar/etiología , Síndrome de Dificultad Respiratoria/fisiopatología , Adulto , Anciano , Ecocardiografía , Femenino , Foramen Oval Permeable/diagnóstico , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Enfermedad Cardiopulmonar/diagnóstico , Respiración Artificial
11.
Orv Hetil ; 156(16): 644-9, 2015 Apr 19.
Artículo en Húngaro | MEDLINE | ID: mdl-25864140

RESUMEN

The authors review the history and risk factors of thrombophlebitis of the lower limb, and describe the main points of surgical and conservative treatment of varicophlebitis. They present the case of a 71-year-old woman who had ascending varicophlebitis and bilateral pulmonary embolism. The authors draw attention to important points: patients must be followed after phlebitis of the lower limb, and their thrombotic factors must be examined to prevent the new thromboembolic events.


Asunto(s)
Paro Cardíaco/etiología , Embolia Pulmonar/complicaciones , Embolia Pulmonar/diagnóstico , Enfermedad Cardiopulmonar/complicaciones , Enfermedad Cardiopulmonar/diagnóstico , Vena Safena/patología , Tromboflebitis/complicaciones , Tromboflebitis/diagnóstico , Várices/complicaciones , Enfermedad Aguda , Anciano , Autopsia , Reanimación Cardiopulmonar , Resultado Fatal , Femenino , Paro Cardíaco/terapia , Humanos , Extremidad Inferior/irrigación sanguínea , Embolia Pulmonar/etiología , Enfermedad Cardiopulmonar/etiología , Vena Safena/diagnóstico por imagen , Tromboflebitis/diagnóstico por imagen , Tromboflebitis/cirugía , Tomografía Computarizada por Rayos X , Insuficiencia del Tratamiento , Ultrasonografía Doppler en Color , Várices/diagnóstico
12.
Herz ; 39(1): 58-65, 2014 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-24638159

RESUMEN

Pulmonary hypertension (PH) is a common phenomenon which may occur as a consequence of various diseases (e.g. heart failure, chronic lung diseases and pulmonary embolism), as a distinct disease of the small pulmonary arterioles or a combination of both. Independent from the origin, PH has an important impact on patient symptoms and prognosis. Establishment of an exact diagnosis and classification as well as an understanding of the hemodynamic interrelationships provide the basis for often challenging treatment decisions. Recently, the fifth World Symposium on PH took place in Nice, France, where important standards and definitions were specified. The most relevant results including the rating of novel treatment options are summarized in this article.


Asunto(s)
Hipertensión Pulmonar/diagnóstico , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/terapia , Neumología/normas , Humanos , Hipertensión Pulmonar/complicaciones , Hipertensión Pulmonar/etiología , Internacionalidad , Guías de Práctica Clínica como Asunto , Enfermedad Cardiopulmonar/etiología , Resultado del Tratamiento
13.
Crit Care Nurs Q ; 37(2): 188-98, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24595256

RESUMEN

Many people throughout the world are living with a severe pulmonary disease, known as pulmonary arterial hypertension. This disease has various etiologies and is often not diagnosed appropriately or early in the disease process, leading to limited, long-term survival. Fortunately in the past 20 years, medications and other options have been developed that provide patients with life-prolonging treatments that also increase their quality of life. Pathophysiology, disease identification and classification, and treatment options, focusing on current pharmacological treatments, are discussed in this article.


Asunto(s)
Antihipertensivos/administración & dosificación , Aprobación de Drogas , Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/terapia , Administración por Inhalación , Administración Oral , Antihipertensivos/farmacología , Terapia Combinada , Epoprostenol/administración & dosificación , Epoprostenol/análogos & derivados , Femenino , Humanos , Hipertensión Pulmonar/epidemiología , Infusiones Intravenosas , Inyecciones Subcutáneas , Masculino , Piperazinas/administración & dosificación , Pronóstico , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/epidemiología , Enfermedad Cardiopulmonar/terapia , Purinas/administración & dosificación , Índice de Severidad de la Enfermedad , Citrato de Sildenafil , Sulfonamidas/administración & dosificación , Tasa de Supervivencia , Resultado del Tratamiento , Estados Unidos , United States Food and Drug Administration
14.
Klin Med (Mosk) ; 92(5): 50-4, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25782307

RESUMEN

AIM: To evaluate the contribution of activation of cytokines and renin-angiotensin-aldosterone system to heart remodeling in patients with chronic obstructive pulmonary disease in the course of a 2 year study and to estimate its relation to severe pulmonary hypertension. MATERIALS AND METHODS: 117 patients with COPD underwent measurement of TNFα, IL-6 levels and renin levels, spirometry and echocardiography (mean pressure in pulmonary artery, MPPA)). The data obtainedwere compared with the degree of remodeling of right and left ventricles. After 2 years 30 and 33 of the 63 patients were referred to groups with aggressive and moderate remodeling of the right ventricle respectively. Regressive analysis was used to detect predictors of aggressive remodeling. RESULTS: Initial remodeling severity and rate showed stronger correlation with TNFα, IL-6 levels and renin levels than with MPPA. Multifactor analysis demonstrated that renin activity and creatinine level were the most reliable predictors of remodeling (p = 0.041 and 0.049 respectively). CONCLUSION: Neurohormonal and imunno-inflammatory changes stimulate remodeling of right and left heart chambers. They independently affect myocardium and their influence is only partly mediated through exacerbation of pulmonary hypertension.


Asunto(s)
Hipertensión Pulmonar , Interleucina-6/sangre , Enfermedad Pulmonar Obstructiva Crónica , Enfermedad Cardiopulmonar , Sistema Renina-Angiotensina , Factor de Necrosis Tumoral alfa/sangre , Remodelación Ventricular , Anciano , Progresión de la Enfermedad , Femenino , Humanos , Hipertensión Pulmonar/etiología , Hipertensión Pulmonar/metabolismo , Hipertensión Pulmonar/fisiopatología , Masculino , Persona de Mediana Edad , Péptido Natriurético Encefálico/sangre , Fragmentos de Péptidos/sangre , Valor Predictivo de las Pruebas , Pronóstico , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/metabolismo , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/etiología , Enfermedad Cardiopulmonar/metabolismo , Enfermedad Cardiopulmonar/fisiopatología , Análisis de Regresión , Renina/sangre , Índice de Severidad de la Enfermedad
15.
Eur Heart J Acute Cardiovasc Care ; 13(3): 304-312, 2024 Mar 11.
Artículo en Inglés | MEDLINE | ID: mdl-38135288

RESUMEN

Acute right ventricular failure secondary to acutely increased right ventricular afterload (acute cor pulmonale) is a life-threatening condition that may arise in different clinical settings. Patients at risk of developing or with manifest acute cor pulmonale usually present with an acute pulmonary disease (e.g. pulmonary embolism, pneumonia, and acute respiratory distress syndrome) and are managed initially in emergency departments and later in intensive care units. According to the clinical setting, other specialties are involved (cardiology, pneumology, internal medicine). As such, coordinated delivery of care is particularly challenging but, as shown during the COVID-19 pandemic, has a major impact on prognosis. A common framework for the management of acute cor pulmonale with inclusion of the perspectives of all involved disciplines is urgently needed.


Asunto(s)
Cardiología , Insuficiencia Cardíaca , Enfermedad Cardiopulmonar , Humanos , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/etiología , Enfermedad Cardiopulmonar/terapia , Pandemias , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/terapia , Ventrículos Cardíacos
16.
Curr Opin Crit Care ; 18(5): 424-31, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22889868

RESUMEN

PURPOSE OF REVIEW: This review summarizes the approach to and recent developments in the evaluation and treatment of acute right heart failure in the ICU. Right heart failure, defined as failure of the right ventricle to provide sufficient blood flow through the pulmonary circulation at normal central venous pressure, is a common problem caused by a combination of increased right-ventricular afterload and right-ventricular contractile dysfunction. RECENT FINDINGS: Management of acute right heart failure continues to be challenging because of insufficient understanding of its pathophysiology, a lack of guidelines, and few available tools. Recent research has contributed to an improved understanding of its mechanisms, helping to guide therapy and suggest future options. Right-ventricular assist devices are emerging as a promising approach to treatment when optimization of hemodynamics and conventional medical therapy fail. SUMMARY: Right heart failure causes venous congestion and systemic hypoperfusion. Once right heart failure is identified, the primary goal is to alleviate any reversible cause of excessive load or right-ventricular contractile failure. When the underlying abnormalities cannot be alleviated, trials of diuretic, vasodilator, or inotropic therapy may be required. Invasive monitoring helps guide therapy. Medically refractory right heart failure may potentially be treated with right-ventricular assist devices.


Asunto(s)
Insuficiencia Cardíaca/diagnóstico , Unidades de Cuidados Intensivos , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Aguda , Gasto Cardíaco , Insuficiencia Cardíaca/tratamiento farmacológico , Insuficiencia Cardíaca/patología , Corazón Auxiliar , Hemodinámica , Humanos , Circulación Pulmonar , Enfermedad Cardiopulmonar/tratamiento farmacológico , Enfermedad Cardiopulmonar/patología
17.
ScientificWorldJournal ; 2012: 757283, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22645449

RESUMEN

BACKGROUND: The prevalence of obstructive sleep apnea (OSA) in the pediatric population is currently estimated at 1-2% of all children. The purpose of this study was to investigate the clinical and hemodynamic characteristics in pediatric patients with cor pulmonale and OSA. METHODS: Thirty children with the diagnosis of OSA were included. These patients consisted of 26 male and 4 female children with a mean age of 7 ± 4 years old. Five of those children were found to be associated with cor pulmonale, and 25 had OSA but without cor pulmonale. RESULTS: The arousal index was much higher in children with OSA and cor pulmonale. The children with OSA and cor pulmonale had much lower mean and minimal oxygen saturation and a higher incidence of bradycardia events. All 5 patients with OSA and cor pulmonale underwent an adenotonsillectomy, and the pulmonary arterial pressure dropped significantly after the surgery. CONCLUSION: This study demonstrated that the OSA pediatric patients with cor pulmonale had the different clinical manifestations and hemodynamic characteristics from those without cor pulmonale. The adenotonsillectomy had excellent results in both the OSA pediatric patients with and without cor pulmonale.


Asunto(s)
Enfermedad Cardiopulmonar/complicaciones , Enfermedad Cardiopulmonar/diagnóstico , Apnea Obstructiva del Sueño/complicaciones , Apnea Obstructiva del Sueño/diagnóstico , Adenoidectomía/métodos , Adolescente , Bradicardia/complicaciones , Niño , Preescolar , Ecocardiografía/métodos , Electrocardiografía/métodos , Femenino , Hemodinámica , Humanos , Masculino , Polisomnografía/métodos , Factores de Riesgo , Tonsilectomía/métodos
18.
Pneumonol Alergol Pol ; 80(6): 541-5, 2012.
Artículo en Polaco | MEDLINE | ID: mdl-23109206

RESUMEN

This paper presents cardiologist's point of view on definition, diagnosis and treatment of pulmonary heart disease. Difficulties in interpretation of definition in clinical praxis and the role of medical history, physical examination, lung function tests, gasometry, chest X-ray and ECG in initial diagnosis of pulmonary heart disease are described. Author underlines the importance of echocardiographic study and pulmonary hemodynamics in confirmation of diagnosis and in differential diagnosis of "out of proportion" pulmonary hypertension. The current results of specific for pulmonary artery hypertension vasodilatory treatment in patients with pulmonary heart disease are discussed.


Asunto(s)
Cardiología/normas , Circulación Coronaria , Rol del Médico , Circulación Pulmonar , Enfermedad Cardiopulmonar/diagnóstico , Enfermedad Cardiopulmonar/prevención & control , Diagnóstico Diferencial , Diagnóstico Precoz , Hemodinámica , Humanos , Medición de Riesgo , Factores de Riesgo
19.
Zhong Xi Yi Jie He Xue Bao ; 10(9): 970-4, 2012 Sep.
Artículo en Zh | MEDLINE | ID: mdl-22979927

RESUMEN

OBJECTIVE: To select appropriate descriptors for response of the patient-reported outcome (PRO) scale for the main symptoms of patients with chronic obstructive pulmonary disease (COPD) complicated with pulmonary heart disease. METHODS: A cross-sectional investigation was carried out. Five equidistant ordinal descriptive words in the PRO scale of main symptoms for COPD complicated with pulmonary heart disease were selected. There were 32 alternative words in the questionnaire. Thirty respondents were required to place each descriptive word on a 10-centimeter line according to where they considered each descriptive word should be placed. Then, the line was measured by ruler; average, standard deviation and median were calculated by excel software; the authors finally chose the five equidistant words which accurately reflect the degree of main symptoms. RESULTS: The five most appropriate descriptive words were selected; they were "never", "seldom", "half-partly sometimes", "very often" and "always". CONCLUSION: These selected decorated words are suitable for the PRO scale for patients with COPD complicated with pulmonary heart disease.


Asunto(s)
Medicina Tradicional China/métodos , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Cardiopulmonar/diagnóstico , Encuestas y Cuestionarios , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Cardiopulmonar/complicaciones , Adulto Joven
20.
Artículo en Zh | MEDLINE | ID: mdl-22730692

RESUMEN

OBJECTIVE: To determine the value of terminal force of P wave in V1 lead (Ptf-V1) in the diagnosis of coal-workers' pneumoconiosis with pulmonary heart disease complicated by left ventricular hypertrophy. METHODS: Select the coal-worker with pneumoconiosis postmortem examination cases which were pathologically diagnosed as pulmonary heart disease complicated by left ventricular hypertrophy and can measure Ptf-V1. Select 14 cases with ECG left axis deviation, no deviation and right axis deviation. Measure and analyze the Ptf-V1 value, the thickness of left and right ventricular wall. RESULTS: There's obvious discrepancy in ventricular wall thickness mean in ECG left axis deviation, no deviation and right axis deviation groups, the discrepancy have statistical significance (F1 = 32.18, P < 0.01, F2 = 8.02, P < 0.01). The left ventricular wall is thicker in ECG left axis deviation group [(1.81 +/- 0.18) cm] than in no deviation [(1.47 +/- 0.15) cm] and right axis deviation groups [(1.39 +/- 0.10) cm], the discrepancy have statistical significance with (P < 0.01). The right ventricular wall is thicker in ECG left axis deviation group [(0.79 +/- 0.14) cm] than in no deviation group [(0.58 +/- 0.14) cm], the discrepancy have statistical significance with (P < 0.01). The right ventricular wall is thicker in ECG right axis deviation group [(0.71 +/- 0.14) cm] than in no deviation group, the discrepancy have statistical significance with (P < 0.05). ECG left axis deviation Ptf-V1 relevance ratio 85.71% is higher than in no deviation (35.70%) and right axis deviation groups (28.57%), the discrepancy have statistical significance with (P < 0.01). The Ptf-V1 absolute value is positively related with left ventricular wall thickness in ECG left axis deviation and no deviation groups (r1 = 0.92, P < 0.01, r2 = 0.93, P < 0.01). CONCLUSION: Pft-V1 absolute value is the criterion index of left ventricular morphosis and function especially left atrium loading change. ECG Ptf-V1 combined with ECG left axis deviation is valuable to the diagnosis of coal-workers with pneumoconiosis complicated by left ventricular hypertrophy.


Asunto(s)
Antracosis/fisiopatología , Electrocardiografía , Hipertrofia Ventricular Izquierda/diagnóstico , Enfermedad Cardiopulmonar/diagnóstico , Anciano , Antracosis/complicaciones , Humanos , Hipertrofia Ventricular Izquierda/complicaciones , Hipertrofia Ventricular Izquierda/fisiopatología , Persona de Mediana Edad , Enfermedad Cardiopulmonar/complicaciones , Enfermedad Cardiopulmonar/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA